Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H R Hoogenboom

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Nature Biotechnology|February 1, 1997
Mix and match: building manifold binding sitesH R Hoogenboom
Trends in Biotechnology|February 1, 1997
Designing and optimizing library selection strategies for generating high-affinity antibodiesH R Hoogenboom
Immunology Today|August 1, 2000
Natural and designer binding sites made by phage display technologyH R Hoogenboom, P Chames
Journal of Molecular Biology|September 20, 1992
By-passing immunisation. Human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitroH R Hoogenboom, G Winter
Trends in Biotechnology|January 1, 1995
Artificial antibodies and enzymes: mimicking nature and beyondP Holliger, H R Hoogenboom
Molecular Immunology|September 1, 1991
Construction and expression of antibody-tumor necrosis factor fusion proteinsH R Hoogenboom, G Volckaert, J C Raus
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1990
Cloning and expression of a chimeric antibody directed against the human transferrin receptorH R Hoogenboom, J C Raus, G Volckaert
Biochimica Et Biophysica Acta|June 5, 1991
Targeting of tumor necrosis factor to tumor cells: secretion by myeloma cells of a genetically engineered antibody-tumor necrosis factor hybrid moleculeH R Hoogenboom, J C Raus, G Volckaert
European Journal of Biochemistry|January 5, 1999
Protein LA, a novel hybrid protein with unique single-chain Fv antibody- and Fab-binding propertiesH G Svensson, H R Hoogenboom, U Sjöbring
Springer Seminars in Immunopathology|January 1, 1996
Targeting of peripheral blood T lymphocytesR L Bolhuis, H R Hoogenboom, J W Gratama
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Nature Biotechnology|February 1, 1997
Mix and match: building manifold binding sitesH R Hoogenboom
Trends in Biotechnology|February 1, 1997
Designing and optimizing library selection strategies for generating high-affinity antibodiesH R Hoogenboom
Immunology Today|August 1, 2000
Natural and designer binding sites made by phage display technologyH R Hoogenboom, P Chames
Journal of Molecular Biology|September 20, 1992
By-passing immunisation. Human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitroH R Hoogenboom, G Winter
Trends in Biotechnology|January 1, 1995
Artificial antibodies and enzymes: mimicking nature and beyondP Holliger, H R Hoogenboom
Molecular Immunology|September 1, 1991
Construction and expression of antibody-tumor necrosis factor fusion proteinsH R Hoogenboom, G Volckaert, J C Raus
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1990
Cloning and expression of a chimeric antibody directed against the human transferrin receptorH R Hoogenboom, J C Raus, G Volckaert
Biochimica Et Biophysica Acta|June 5, 1991
Targeting of tumor necrosis factor to tumor cells: secretion by myeloma cells of a genetically engineered antibody-tumor necrosis factor hybrid moleculeH R Hoogenboom, J C Raus, G Volckaert
European Journal of Biochemistry|January 5, 1999
Protein LA, a novel hybrid protein with unique single-chain Fv antibody- and Fab-binding propertiesH G Svensson, H R Hoogenboom, U Sjöbring
Springer Seminars in Immunopathology|January 1, 1996
Targeting of peripheral blood T lymphocytesR L Bolhuis, H R Hoogenboom, J W Gratama
Pageof 7